Apitoria Pharma Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is VORICONAZOLE USP, with a corresponding US DMF Number 27842.
Remarkably, this DMF maintains an Active status since its submission on January 07, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 26, 2014, and payment made on January 06, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II